Prevalence and clinical characteristics of microalbuminuria in the Spanish hypertensive population;Prevalencia y características clínicas de la microalbuminuria en la población española con hipertensión arterial

Medicina Clinica

Volumn 130, Issue 6, 2008, Pages 201-205

  De La Sierra, Alejandro ^a   Egocheaga, María Isabel ^b   Aguilera, María Teresa ^c  

^a HOSPITAL CLÍNIC   (Spain)

^b Centro de Salud Isla de Oza   (Spain)

^c Centro de Investigation Basica Sanofi Aventis   (Spain)

Author keywords

Hypertension; Microalbuminuria; Target organ damage; Urinary albumin excretion

Indexed keywords

ALBUMIN; CREATININE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE URINE LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; HEALTH CENTER; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PREVALENCE; PRIMARY MEDICAL CARE; PROTEINURIA; SMOKING; SPAIN; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; URINALYSIS; URINARY EXCRETION;

EID: 42049116554     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13116170     Document Type: Article

References (28)

1. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011-53.
2. Marín R, De la Sierra A, Armario P, Campo C, Banegas JR, Gorostidi M. Guía sobre el diagnóstico y tratamiento de la hipertensión arterial en España 2005. Med Clin (Barc). 2005;125:24-34.
3. Brosius FC, Hostetter TH, Kelepouris E, Mitsnefes MM, Moe SM, Moore MA, et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease. A science advisory form the American Heart Association Kidney and Cardiovascular Disease Council; the Councils for High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2006;114:1083-7.
4. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. 1987;1:1430-2.
5. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med. 1984;310:356-60.
6. Pedrinelli R, Dell'Omo G, Catapano G, Giampietro O, Carmassi F, Matteucci E, et al. Microalbuminuria and endotelial dysfunction in essential hypertension. Lancet. 1994;344:14-8.
7. Jager A, Kostense PJ, Ruhe HG, Heine RJ, Nijpels G, Dekker JM, et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol. 1999;19:617-24.
8. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension. 2000;35:898-903.
9. Romundstad S, Holmen J, Hallan H, Kvenild K, Ellekjaer H. Microalbuminuria and all-cause mortality in treated hypertensive individuals. Does sex matter? The Nord-Trøndelag Health Study (HUNT), Norway. Circulation. 2003;108:2783-9.
10. Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med. 2003;139:901-6.
11. Dell'Omo G, Penno G, Giorgi D, Di Bello V, Mariani M, Pedrinelli R. Association between high-normal albuminuria and risk factors for cardiovascular and renal disease in essential hypertensive men. Am J Kidney Dis. 2002;40:1-8.
12. De la Sierra A, Bragulat E, Sierra C, Gómez-Angelats E, Antonio MT, Aguilera MT, et al. Microalbuminuria in essential hypertension: clinical and biochemical profile. Br J Biomed Sci. 2000; 57:287-91.
13. Pontremoli R, Nicolella C, Viazzi F, Ravera M, Sofia A, Berruti V, et al. Microalbuminuria is an early marker of target organ damage in essential hypertension. Am J Hypertens. 1998;11:430-8.
14. Leoncini G, Sacchi G, Viazzi F, Ravera M, Parodi D, Ratto E, et al. Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach. J Hypertens. 2002;20:1315-21.
15. Wachtell K, Olsen MH, Dahlöf B, Devereux RB, Kjeldsen SE, Nieminen MS, et al. Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. J Hypertens. 2002;20:405-12.
16. Palatini P, Mormino P, Mos L, Mazzer A, Dorigatti F, Zanata G, et al. Microalbuminuria, renal function and development of sustained hypertension: a longitudinal study in the early stage of hypertension. J Hypertens. 2005;23:175-82.
17. Palatini P, Graniero GR, Mormino P, Mattarei M, Sanzuol F, Cignacco GB, et al. Prevalence and clinical correlates of microalbuminuria in stage I hypertension. Results from the Hypertension and Ambulatory Recording Venetia Study (HARVEST Study). Am J Hypertens. 1996;9:334-41.
18. Pontremoli R, Sofia A, Ravera M, Nicolella C, Viazzi F, Tirotta A, et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension. The MAGIC Study. Hypertension. 1997;30:1135-43.
19. Bigazzi R, Bianchi S, Baldari D, Campese VM. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens. 1998;16:1325-33.
20. Redon J, Liao Y, Lozano JV, Miralles A, Pascual JM, Cooper RS. Ambulatory blood pressure and microalbuminuria in essential hypertension: role of circadian variability. J Hypertens. 1994;12: 947-53.
21. Bonet J, Vila J, Alsina MJ, Ancochea L, Romero R. Prevalencia de microalbuminuria en la población general de un área mediterránea española y su asociación con otros factores de riesgo cardiovascular. Med Clin (Barc). 2001;116: 573-4.
22. Aguirre B. Prevalencia de microalbuminuria en una población hipertensa del norte de Navarra y su relación con otros factores de riesgo cardiovascular. An Sist Sanit Navar. 2004;27: 27-36.
23. Giner V, Tormos C, Chaves FJ, Saez G, Redon J. Microalbuminuria and oxidative stress in essential hypertension. J Intern Med. 2004;255:588-94.
24. Robles NR, Velasco J, Mena C, Angulo E, Garrote T. Microalbuminuria en pacientes diabéticos y en pacientes con hipertensión arterial: estudio de una cohorte de 979 pacientes. Med Clin (Barc). 2006;127:761-4.
25. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation. 2002;106:3143-421.
26. Cerasola G, Cottone S, Mule G, Nardi E, Mangano MT, Andronico G, et al. Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension. J Hypertens. 1996;14: 915-20.
27. Gerber LM, Schwartz JE, Cedeno-Mero C, Warren K, Pickering TG. Association of urinary albumin concentration with casual and ambulatory blood pressure: a similar relationship in normotensive and hypertensive subjects. Blood Press Monit. 2001;6:245-51.
28. Redon J. Antihypertensive treatment: should it be titrated to blood pressure reduction or to target organ damage regression? Curr Opin Nephrol Hypertens. 2005;14:448-52.